Abstract
The authors review the extent of the use of nonprescription drugs as well as possible variables influencing such consumption. Various studies indicate that age, sex, personality characteristics, perceptions of health status, socioeconomic factors, parental example, and pharmacists all play parts in determining over-the-counter (OTC) drug utilization. Several sources express concern about the inaccessibility of accurate OTC drug information to the consumer. Indeed, even the FDA has occasional difficulty obtaining reliable facts on both the numbers and formulae of such products. Several studies indicate that consumers acquire information about their home remedies through advertising, friends and relatives, physicians, pharmacists, and product labels. By far the most influential of these is advertising, and much concern has been voiced over consumers' unquestioning faith in drug ads. Examples are cited of deceptive, inaccurate, and unfair advertising practices used by some OTC drug manufacturers. The pros and cons of the “drug-oriented society” theory are discussed, including an analysis of its underlying origins. Testing of the safety and efficacy of non-rescription remedies has proved to be controversial, especially when considering the ramifications of the placebo effect. Different surveys report widespread misuse of OTCs by consumers through overuse, taking several drugs concurrently, and using home remedies to treat potentially serious diseases.
The fact that life is a multi-faceted process, that pain, sorrow, discouragement, and tension are as much a part of life as joy, peace, and pleasure, has been lost on many of the older generation as well as on the adolescents of today. The fact that a sleepless night may produce an important insight into one's self, or the nature of the universe, or that several days of depression can be a growth-inducing experience, seems to be lost on too many of us.
—G.K. Piorkowski
Similar content being viewed by others
References
Fry J: The medical aspect of home medication and its advantages to the general practitioner.WFPMM 1st General Assembly Report. London, 1971. Pp 19–21.
Knapp DA, Knapp D: Decision-making and self-medication: Preliminary findings.Am J Hosp Pharm 29 1004–1012, 1972.
Johnson RE, et al: Reported use of nonprescribed drugs in health maintenance.Am J Hosp Pharm 33 1249–1254, 1976.
Silverman M, Lee PR:Pills, Profits and Politics. Berkeley, University of California Press, 1974. Pp 206–233, 276–278.
The Size and Shape of the Medical Care Dollar, 1969. Washington, DC, Social Security Administration, 1970.
Prescription Drug Data Summary. Social Security Administration, DHEW Publication No SSA 73-11900, Washington, DC, Government Printing Office, 1972.
Illich I: Medical nemesis.Lancet 1918–921, 1974.
Kohn R, White KL:Health Care—An International Study. London, Oxford University Press, 1976. Pp 223–276.
Sorensen A, Roghmann K: Use of over-the-counter and prescription drugs among pre-school children. Presented at the annual meeting of the American Public Health Association, 1976.
Ziff R: Psychographics for market segmentation.J Adver Res 11 3–9, 1971.
Blum RH: Normal drug use. In RH Blum et al (eds):Society and Drugs. San Francisco, Jossey-Bass, 1969. Pp 245–275.
Lewis CE, Lewis MA: The impact of television commercials on health-related beliefs and behaviors of children.Pediatrics 53 431–435, 1974.
Knapp DE, Knapp DA, Oeltjen P: OTC decision-making: Using a nonprescription drug for the first time.Med Marketing and Media 1026, 28–29, 1975.
Griffenhagen G: Is self-medication emerging from the dark ages?Trial 12 26, 29–30, 1976.
Bicket WJ: Statement of the American Pharmaceutical Association to the Monopoly Subcommittee of the Senate Small Business Committee of the United States Senate. 92nd Congress, 1st Session, 1971. Pp 468–473.
Kuriansky JB: TV advertising and abuse of OTC drugs. New York, Subcommittee on Drugs and Other Toxic Substances, New York Scientists' Committee for Public Information, 1975 (Mimeographed).
Angevine E: The concerned consumer.J AM Pharm Assoc 12 356–357, 1972.
Food and Drug Administration:Consumer Attitudes Toward Over-the-Counter Drug Labels. Department of Commerce, National Technical Information Service, PB-254259: 10–11, 16.
Food and Drug Administration:Consumers and Medication. National Technical Information Service, Department of Commerce, May 1974.
A Study of Health Practices and Opinions. Philadelphia, National Analysts, 1972. P 140.
Gaines J: Some possible psychological dynamics of consumer health misconceptions.J Sch Health 38 489–493, 1968.
Hodes B: Nonprescription drugs: An overview.Int J Health Serv 4 125–130, 1974.
Smith FA, et al: Health information during a week of television.N Engl J Med 286 516–520, 1972.
Peterson B, et al: Television advertising and drug use.Am J Public Health 66 975–978, 1976.
Lewis DC: Advertising of proprietary medicines. Statement in the U.S. Senate 2: 769–780, July 22, 1971.
McEwen WJ, Hanneman GJ: The depiction of drug use in television programming.J Drug Educ 4 281–293, 1974.
A new breed of consumers will be calling the turn.U.S. News and World Report 79: 19–20, 1975.
Piorkowski GK: Drug education at its best—The shaping of values and anti-drug attitudes.J Drug Educ 3 31–37, 1973.
Busching BC, Bromley DG: Sources of non-medicinal drug use: A test of the drug-oriented society explanation.J Health Soc Behav 16 50–62, 1975.
Zwardling D: Non-prescription drugs—The ultimate confidence game.New Times 7 36, 38–40, 42, 44–45, 1976.
Koenig P: Lee's bilious pills: The placebo effect in patent medicine.Psychol Today 7 60, 61, 1974.
A Position Paper. Washington, DC, Proprietary Association, October 1, 1971.
Moxley JH III, Yingling GL, Edwards CC: The Food and Drug Administration's O-T-C drug review: Why review OTC drugs?Fed Proc 32 1435–1437, 1973.
Lamy PP, Kitler ME: Untoward effects of drugs, part I.Dis Nerv Syst 32 17–23, 1971.
Penna RP: Advertising of proprietary medicines. Statement in U.S. Senate 1: 360–370, June 16, 1971.
AMA Drug Evaluations. Chicago, American Medical Association, Council on Drugs, 1971.
A Study of Health Practices and Opinions. National Analysts, Inc., FDA-PA 72-01, FDA-66-193, Department of Commerce, National Technical Information Service, PB-210 978, 1972. P 64.
Dangerous food and drugs—behind the furor. Interview with Alexander Schmidt.U.S. News and World Report 80 52–55, 1976.
Additional information
Ms. Esmay is a Research Associate and Dr. Wertheimer is Professor in the College of Pharmacy of the University of Minnesota, Minneapolis, Minnesota, 55455.
Grateful appreciation is expressed to Ms. Noreen Suntrup for her aid in the preparation of the manuscript.
Rights and permissions
About this article
Cite this article
Esmay, J.B., Wertheimer, A.I. A review of over-the-counter drug therapy. J Community Health 5, 54–66 (1979). https://doi.org/10.1007/BF01321571
Issue Date:
DOI: https://doi.org/10.1007/BF01321571